Skip to main content
SpringerLink
Log in

PET-CT of Pancreatic Cancer

  • Chapter
  • First Online:
Clinical PET-CT in Radiology

  • 2211 Accesses

Abstract

Although there are currently a paucity of studies comparing the efficacy of PET-CT with CT and FDG PET alone in pancreatic cancer, results from current studies are promising, and PET-CT is likely to play a significant role in the evaluation and management of patients with pancreatic carcinoma. Its major benefit is in combining the benefits of both anatomical and functional imaging into a single imaging session.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.

    Article  PubMed  Google Scholar 

  2. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997;349:485–489.

    Article  CAS  PubMed  Google Scholar 

  3. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363:1049–1057.

    Article  CAS  PubMed  Google Scholar 

  4. Pakzad F, Groves AM, Ell PJ. The role of positron emission tomography in the management of pancreatic cancer. Semin Nucl Med 2006;36:248–256.

    Article  PubMed  Google Scholar 

  5. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721–731; discussion 31–33.

    Article  CAS  PubMed  Google Scholar 

  6. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. NEJM 2004;350:1200–1210.

    Article  CAS  PubMed  Google Scholar 

  7. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 1998;206:373–378.

    CAS  PubMed  Google Scholar 

  8. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 1997;168:1439–1443.

    CAS  PubMed  Google Scholar 

  9. Farma JM, Santillan AA, Melis M, et al. PET-CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol 2008;15:2465–2471.

    Article  PubMed  Google Scholar 

  10. Imdahl A, Nitzsche E, Krautmann F, et al. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg 1999;86:194–199.

    Article  CAS  PubMed  Google Scholar 

  11. Keogan MT, Tyler D, Clark L, et al. Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol 1998;171:1565–1570.

    CAS  PubMed  Google Scholar 

  12. Zimny M, Bares R, Fass J, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 1997;24:678–682.

    CAS  PubMed  Google Scholar 

  13. Zimny M, Buell U. 18FDG-positron emission tomography in pancreatic cancer. Ann Oncol 1999;10( Suppl 4):28–32.

    Article  PubMed  Google Scholar 

  14. Schick V, Franzius C, Beyna T, et al. Diagnostic impact of (18)F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound. Eur J Nucl Med Mol Imaging 2008;35(10):1775–1785.

    Article  PubMed  Google Scholar 

  15. Inokuma T, Tamaki N, Torizuka T, et al. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. Radiology 1995;195:345–352.

    CAS  PubMed  Google Scholar 

  16. Koyama K, Okamura T, Kawabe J, et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med 2001;15:217–224.

    Article  CAS  PubMed  Google Scholar 

  17. Lytras D, Connor S, Bosonnet L, et al. Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg 2005;22:55–61; discussion 62.

    Article  CAS  PubMed  Google Scholar 

  18. Sendler A, Avril N, Helmberger H, et al. Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations. World J Surg 2000;24:1121–1129.

    Article  CAS  PubMed  Google Scholar 

  19. Wakabayashi H, Nishiyama Y, Otani T, et al. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 2008;14:64–69.

    Article  PubMed  Google Scholar 

  20. Heinrich S, Goerres GW, Schafer M, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 2005;242:235–243.

    Article  PubMed  Google Scholar 

  21. Saif MW, Cornfeld D, Modarresifar H, Ojha B. 18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients. J Gastrointest Liver Dis 2008;17:173–178.

    Google Scholar 

  22. Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994;192:79–86.

    CAS  PubMed  Google Scholar 

  23. Ho CL, Dehdashti F, Griffeth LK, Buse PE, Balfe DM, Siegel BA. FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr 1996;20:363–369.

    Article  CAS  PubMed  Google Scholar 

  24. Mertz HR, Sechopoulos P, Delbeke D, Leach SD. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000;52:367–371.

    Article  CAS  PubMed  Google Scholar 

  25. Stollfuss JC, Glatting G, Friess H, Kocher F, Berger HG, Reske SN. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 1995;195:339–344.

    CAS  PubMed  Google Scholar 

  26. Bang S, Chung HW, Park SW, et al. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. J Clin Gastroenterol 2006;40:923–929.

    Article  PubMed  Google Scholar 

  27. Ozaki Y, Oguchi K, Hamano H, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 2008;43:144–151.

    Article  CAS  PubMed  Google Scholar 

  28. van Kouwen MC, Jansen JB, van Goor H, de Castro S, Oyen WJ, Drenth JP. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging 2005;32:399–404.

    Article  PubMed  Google Scholar 

  29. Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. Q J Nucl Med Mol Imaging 2006;50:15–22.

    CAS  PubMed  Google Scholar 

  30. Tann M, Sandrasegaran K, Jennings SG, Skandarajah A, McHenry L, Schmidt CM. Positron-emission tomography and computed tomography of cystic pancreatic masses. Clin Radiol 2007;62:745–751.

    Article  CAS  PubMed  Google Scholar 

  31. Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. J Gastrointest Surg 2005;9:22–28; discussion 68–69.

    Article  PubMed  Google Scholar 

  32. Mansour JC, Schwartz L, Pandit-Taskar N, et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg 2006;10:1354–1360.

    Article  PubMed  Google Scholar 

  33. Sperti C, Bissoli S, Pasquali C, et al. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2007;246:932–937; discussion 937–939.

    Article  PubMed  Google Scholar 

  34. Maemura K, Takao S, Shinchi H, et al. Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg 2006;13:435–441.

    Article  PubMed  Google Scholar 

  35. Maisey NR, Webb A, Flux GD, et al. FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer 2000;83:287–293.

    Article  CAS  PubMed  Google Scholar 

  36. Nakata B, Nishimura S, Ishikawa T, et al. Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer. Int J Oncol 2001;19:53–58.

    CAS  PubMed  Google Scholar 

  37. Sperti C, Pasquali C, Chierichetti F, Ferronato A, Decet G, Pedrazzoli S. 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma. J Gastrointest Surg 2003;7:953–959; discussion 959–960.

    Article  PubMed  Google Scholar 

  38. Yoshioka M, Sato T, Furuya T, et al. Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer. J Gastroenterol 2004;39:50–55.

    Article  PubMed  Google Scholar 

  39. Gress FG, Hawes RH, Savides TJ, et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999;50:786–791.

    Article  CAS  PubMed  Google Scholar 

  40. Lemke AJ, Niehues SM, Hosten N, et al. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions – a prospective study with 104 patients. J Nucl Med 2004;45:1279–1286.

    PubMed  Google Scholar 

  41. Nishiyama Y, Yamamoto Y, Yokoe K, et al. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Ann Nucl Med 2005;19:491–497.

    Article  PubMed  Google Scholar 

  42. Franke C, Klapdor R, Meyerhoff K, Schauman M. 18-FDG positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma. Anticancer Res 1999;19:2437–2442.

    CAS  PubMed  Google Scholar 

  43. Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN. Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 1999;40:250–255.

    CAS  PubMed  Google Scholar 

  44. Strobel K, Heinrich S, Bhure U, et al. Contrast-enhanced 18F-FDG PET-CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. J Nucl Med 2008;49(9):1408–1413.

    Article  PubMed  Google Scholar 

  45. Ruf J, Lopez Hanninen E, Oettle H, et al. Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI. Pancreatology 2005;5:266–272.

    Article  PubMed  Google Scholar 

  46. Shreve PD. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med 1998;25:259–264.

    Article  CAS  PubMed  Google Scholar 

Further Reading

  1. Federle MP, Anne, V.S. Pancreatic ductal carcinoma. In: Federle MP (ed.). Diagnostic Imaging: Abdomen. Salt Lake City: Amirsys, 2004:II-3–50.

    Google Scholar 

  2. Kalra MK, Maher MM, Mueller PR, Saini S. State-of-the-art imaging of pancreatic neoplasm. Br J Radiol 2003;76:857–865.

    Article  CAS  PubMed  Google Scholar 

  3. Kim YH, Saini S, Sahani D, Hahn PF, Mueller PR, Auh YH. Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst. RadioGraphics 2005;25:671–685.

    Article  PubMed  Google Scholar 

  4. Sahani DV, Kadavigere R, Saokar, A, Castillo CF, Brugge WR, Hahn PF. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. RadioGraphics 2005;25:1471–1485.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. FRG Molecular Imaging, Foundation Radiology Group, 401 Liberty Avenue, Suite 2000, Pittsburgh, PA, 15222, USA

    Todd M. Blodgett

Authors
  1. Todd M. Blodgett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjay Paidisetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Shreve
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Todd M. Blodgett .

Editor information

Editors and Affiliations

  1. Advanced Radiology Services, North Evergreen Drive 3264, Grand Rapids, 49525, Michigan, USA

    Paul Shreve

  2. , Head, PET and SPECT Development, Singapore Bioimaging Consortium, 11 Biopolis Way #02-02 Hel, Singapore, 138667, Singapur, Singapore

    David W. Townsend

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Blodgett, T.M., Paidisetty, S., Shreve, P. (2011). PET-CT of Pancreatic Cancer. In: Shreve, P., Townsend, D. (eds) Clinical PET-CT in Radiology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-48902-5_31

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-48902-5_31

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-48900-1

  • Online ISBN: 978-0-387-48902-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation